The risk of T cell NHL was found to be higher in patients receiving simultaneous treatment with TNF-a inhibitors and thiopurines (95% confidence interval, 4.98–354.09; p < 0.0001) [21]. The gene discussed is TNF; the disease is T-cell non-Hodgkin lymphoma.